Monsanto Company (NYSE: MON) today announced that it has entered into an agreement to sell its POSILAC(R) bovine somatotropin brand ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE